Insider Trading & Ownership of Ph.D. Jay R. Luly

Location
Watertown, MA
Summary
The estimated net worth of Ph.D. Jay R. Luly is at least $12,424,161 dollars as of 13 Feb 2026. Ph.D. Jay R. Luly is the President and CEO, Director of ENANTA PHARMACEUTICALS INC and owns shares of ENANTA PHARMACEUTICALS INC (ENTA) stock worth about $12.42M.
Signature
/s/ Matthew Kowalsky as attorney-in-fact
All Insider Reports
All Insider Reports

Follow Filing Activity

Follow Ph.D. Jay R. Luly and return when a new Insider Trading filing appears.

This tracks SEC filing changes for this page using existing product update flows.

Sign up to save research and follow filings

Sponsored

Quick Takeaways

  • Ph.D. Jay R. Luly has 1 issuer position tracked on this page.
  • Estimated disclosed ownership value: $12,424,161.
  • Recent insider filing activity is available below.

What Changed

  • Largest disclosed position: ENANTA PHARMACEUTICALS INC ($12,424,161).
  • Past-year value change for that position: -$67,493.

Why This Matters

  • This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
  • You can cross-check role, issuer, and filing chronology directly against the SEC source.

Official SEC Source

Filed on Form 4

Insider ownership context is sourced from SEC Forms 3, 4, and 5.

See Original Filing

Ownership of Ph.D. Jay R. Luly

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
ENTA ENANTA PHARMACEUTICALS INC President and CEO, Director $12,424,161 -$67,493 -0.54% 12 Feb 2026

Insider Transactions Reported by Ph.D. Jay R. Luly:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Sponsored